Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06864819 · ClinicalTrials.gov registry record

Role of Phosphatidylethanol in Predicting Perioperative Outcomes of Admitted Patients at UHCMC

A clinical trial of Alcohol Use Disorder and Postoperative Complications, sponsored by University Hospitals Cleveland Medical Center.

Recruiting
Registry status
170
Enrollment target
1
Study location

NCT06864819 is a study of Alcohol Use Disorder and Postoperative Complications that is actively recruiting participants, run by University Hospitals Cleveland Medical Center. The registered enrollment target is 170 participants, below the 328-participant average among 184 other Alcohol Use Disorder trials with a reported enrollment target (48% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06864819, a study of Alcohol Use Disorder and Postoperative Complications, is actively recruiting participants, sponsored by University Hospitals Cleveland Medical Center.

RECRUITING
Registry status
170 participants
Enrollment target
1
Study location

Study Summary

This study aims to see if there's a link between a substance called phosphatidylethanol (PEth) and how patients who have surgery at University Hospitals do after surgery. PEth levels reflect the amount of alcohol use by someone over the past few weeks. This study is checking PEth levels on all patients who are planned to stay in the hospital for three or more days after surgery regardless if they drink alcohol. Specifically, it will look at if PEth levels are connected to problems that might come up during and after surgery, like confusion, lung or heart issues, needing blood transfusions, infections, unexpected intensive care unit (ICU) stays, and longer hospital stays. While there are reports of moderate alcohol consumption being good for the heart, there are other data that alcohol consumption can be harmful. Since there's not much information on how drinking alcohol affects health outcomes during and after surgery, especially for patients who are planned to be admitted to the hospital ward or ICU after surgery, this study will hopefully see if PEth levels before surgery can predict how patients do after the surgery. The inclusion criteria to only include patients who consume alcoholic beverages was an IRB approved modification after already recruiting 1/3 of patients.

Interventions

  • OTHER Blood Draw

Study Locations (1)

Ohio

  • University Hospital - Cleveland

Trial Details

FieldValue
Enrollment Target 170 participants
Start Date 2025-05-05
Est. Completion 2026-08-01

What the Registry Record Tells You About NCT06864819

The ClinicalTrials.gov registry entry for NCT06864819 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 170 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 328-participant average among 184 other Alcohol Use Disorder trials with a reported enrollment target (48% lower). The listed sponsor is University Hospitals Cleveland Medical Center, which has 230 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Alcohol Use Disorder appearing as the primary indexed condition, and to 1 intervention - of which Blood Draw is the first listed.

NCT06864819 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT06864819 about?

NCT06864819 is a clinical study titled "Role of Phosphatidylethanol in Predicting Perioperative Outcomes of Admitted Patients at UHCMC". This study aims to see if there's a link between a substance called phosphatidylethanol (PEth) and how patients who have surgery at University Hospitals do after surgery. PEth levels reflect the amount of alcohol use by someone over the past few weeks. This study is checking PEth levels on all patie...

What is the current status of trial NCT06864819?

This trial is currently recruiting. The enrollment target is 170 participants. The study started on 2025-05-05. Estimated completion is 2026-08-01.

What conditions does trial NCT06864819 study?

This clinical trial studies the following conditions: Alcohol Use Disorder, Postoperative Complications.

What interventions are being tested in trial NCT06864819?

The interventions under investigation include: Blood Draw (OTHER).

Who is sponsoring clinical trial NCT06864819?

This trial is sponsored by University Hospitals Cleveland Medical Center, which has 230 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06864819 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Alcohol Use Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.